Joel Thompson
Medical · Charlotte, NCNPI 1366429094
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $184,945 of the $265,090 with a category attached, or 69.8%. Viiv Healthcare Company accounts for 62.1% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2024 at $91,741 and has fallen 88.7% since, to $10,392 in 2025. Among medical clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 712 payments — averaging $372.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$165K
- Janssen Products, LP$47K
- Gilead$42K
- Napo Pharmaceuticals Inc$7K
- Theratechnologies Inc.$2K
- Johnson & Johnson$789
- plus $2K from 32 others
Across 2 payments — averaging $1750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Theratechnologies Inc.$4K
What the payments were for
- Consulting fees$7,2183%
- Speaking & faculty fees$184,94570%
- Travel & lodging$58,10722%
- Food & beverage$14,6126%
- Education$2080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 335 | $164,753 |
| Janssen Products, LP | 47 | $46,836 |
| Gilead | 148 | $42,372 |
| Napo Pharmaceuticals Inc | 28 | $6,788 |
| Theratechnologies Inc. | 3 | $1,547 |
| Johnson & Johnson(2 entities) | 35 | $789 |
| Novartis | 12 | $223 |
| AbbVie | 14 | $203 |
| Amgen | 14 | $183 |
| Merck | 11 | $182 |
| Boehringer Ingelheim | 7 | $125 |
| Novo Nordisk | 6 | $100 |
| Biohaven Pharmaceuticals, Inc. | 5 | $92 |
| Clarus Therapeutics Inc. | 4 | $84 |
| Antares Pharma, Inc. | 4 | $83 |
| AstraZeneca | 3 | $81 |
| Pfizer | 3 | $57 |
| Lilly USA, LLC | 4 | $55 |
| Indivior Inc. | 2 | $52 |
| Corcept Therapeutics | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Insightec,inc | 1 | $33 |
| Janssen Scientific Affairs, LLC | 2 | $32 |
| Amarin Pharma, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Edwards Lifesciences | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Organon | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| VBI Vaccine (delaware) Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$265,090 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.
Other medical in Charlotte
- Rochelle LunaCharlotte$19K
- Dana DorenfeldCharlotte$17K
- Keri SquittieriCharlotte$17K
- Tonya FraserCharlotte$16K
- Lisa MatugaCharlotte$15K
- Claire HolmquistCharlotte$14K
- Tyler HyslepCharlotte$13K
- Rahele MohseniCharlotte$12K
- Rachelle CroninCharlotte$10K
- Arica SargentCharlotte$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.